Ankasa Regenerative Therapeutics
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$9.5M
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of bio-pharmaceutical strategies designed to improve tissue healing. The company's bio-pharmaceutical strategies utilizes proprietary formulations of a potent WNT stem cell activator that accelerates tissue healing, enabling patients to avail demonstrated superiority in terms of bone reformation over existing standards of care in various preclinical models.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
- 11099 North Torrey Pines Road
- Suite 290
- San Diego, CA 92037
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Ankasa Regenerative Therapeutics’s full profile, request a free trial.
Ankasa Regenerative Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 30-Jul-2015 | $9.5M | 00.00 | Completed | Startup |
Ankasa Regenerative Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Avalon Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Correlation Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| JLABS | Accelerator/Incubator | 000 0000 | 000000 0 |